Basauri A, Gonzlez-Fernndez C, Fallanza M, Bringas E, Fernandez-Lopez R, Giner L, et al
Built on a 39-amino acid GIP backbone, it simultaneously activates three distinct receptor systems: GLP-1, GIP, and glucagon receptors
Novo Nordisk has indicated its intention to submit CagriSema for regulatory review following the completion of the REDEFINE Phase 3 programme
109 MizunoY.SuzukiK.OhtaS
15:30071 Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective Pickart L, Vasquez-Soltero JM, Margolina A., BioMed Research International , 2015
(2003) Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases